Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


LIFNano is a simple and safe technology set to unlock new treatments for a number of neurodegenerative diseases. Founder of the technology, Dr Su Metcalfe believes it could well be the cure for MS...

Research has found that children are 10 times more likely than adult patients to generate key proteins used to identify multiple sclerosis (MS). This means that a simple blood test could speed up...

Minocycline, a common acne drug, has been found to delay the progress of multiple sclerosis (MS) for patients in the early stages of the condition. 

The Canadian study was published in the...

It has been reported by Reuters, that Roche, the maker of Ocrevus, is investigating a case of patient illness after taking its drug.

The patient, who lives in Germany, was treated with the...

A drug, proven to improve walking in people with MS, has been approved and given standard marketing authorisation by the European Commission (EC). 

Fampyra (prolonged release fampridine...

In a phase III trial, 2,199 relapsing remitting multiple sclerosis (RRMS) patients were randomised to receive one of two doses of laquinimod or a placebo. 

Last year drug makers stopped...

Scientists have discovered an experimental treatment that targets activated immune cells, killing them off and stopping autoimmune damage. 

In a study, researchers at Cincinnati Children’s...

Researchers from the University of British Columbia conducted a study to identify potential adverse events related to beta-interferon treatment for relapsing remitting multiple sclerosis (RRMS...

Ian Duncan, a professor of veterinary medicine at the University of Wisconsin-Madison, has pinpointed the cause of a serious neurological disease, very similar to multiple sclerosis (MS), in a...

According to research, exposure to the Epstein-Barr virus and herpes simplex virus type 1 (HSV-1) during childhood, in addition to a vitamin D deficiency, could increase the risk of developing...

Pages

Live Chat Software by Click4Assistance UK